Roy D. Baynes, Director of Natera NTRA, has filed 0 purchases and 22 sales on the open market. Over the past 12 months that comes to a net sale of $5.4M. The latest trade was on 06/26.

RB

RB

Roy D. Baynes

Director

Company

Natera NTRA

First filing

23/01/18

Trades

89 trades

Buys / sales

0 / 22

12-month net buying

−$5.4M

Last trade

06/26

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Travere TherapeuticsTVTX	Open-market sale10b5-1 plan	06/12	06/16	4,500 sh	$50.00	$225,000	−9.8%
Travere TherapeuticsTVTX	Open-market sale10b5-1 plan	05/05	05/06	4,500 sh	$46.65	$209,925	−10.7%
Travere TherapeuticsTVTX	Open-market sale10b5-1 plan	05/01	05/04	9,750 sh	$44.22	$431,145	−20.6%
Travere TherapeuticsTVTX	Open-market sale10b5-1 plan	04/14	04/16	32,750 sh2 trades	$41.29avg.	$1,352,130	−46.6%
Travere TherapeuticsTVTX	Open-market sale10b5-1 plan	04/06	04/07	10,000 sh	$33.00	$330,000	−21.1%
NateraNTRA	Open-market sale10b5-1 plan	25/11/19–25/11/20	25/11/21	12,780 sh8 trades	$219.85avg.	$2,809,686.8	−41.0%
Travere TherapeuticsTVTX	Open-market sale10b5-1 plan	25/02/06	25/02/10	10,000 sh	$22.00	$220,000	−24.4%
Travere TherapeuticsTVTX	Open-market sale10b5-1 plan	25/01/23	25/01/23	16,000 sh	$20.00	$320,000	−34.0%
NateraNTRA	Open-market sale10b5-1 plan	24/11/15	24/11/15	37,230 sh6 trades	$146.11avg.	$5,439,575.59	−70.2%